Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

JAK2 V617F

Clinical trials for JAK2 V617F explained in plain language.

Never miss a new study

Get alerted when new JAK2 V617F trials appear

Sign up with your email to follow new studies for JAK2 V617F, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • Can newer blood thinners beat aspirin for clot prevention in blood cancer patients?

    Disease control Recruiting now

    This phase 3 trial is testing whether direct oral anticoagulants (DOACs) like apixaban or rivaroxaban are better than low-dose aspirin at preventing blood clots in people with JAK2V617F-positive myeloproliferative neoplasms (blood cancers). The study plans to enroll 1308 high-ris…

    Matched conditions: JAK2 V617F

    Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Disease control

    Last updated Jun 27, 2026 11:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space